Growth Metrics

Merck (MRK) Liabilities and Shareholders Equity (2016 - 2025)

Merck (MRK) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $136.9 billion as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity rose 16.87% to $136.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $499.1 billion through Dec 2025, up 10.14% year-over-year, with the annual reading at $136.9 billion for FY2025, 16.87% up from the prior year.
  • Liabilities and Shareholders Equity for Q4 2025 was $136.9 billion at Merck, up from $129.5 billion in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $136.9 billion in Q4 2025, with the low at $90.7 billion in Q2 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $109.4 billion, with a median of $107.1 billion recorded in 2022.
  • The sharpest move saw Liabilities and Shareholders Equity rose 18.09% in 2022, then decreased 2.45% in 2023.
  • Over 5 years, Liabilities and Shareholders Equity stood at $105.7 billion in 2021, then rose by 3.28% to $109.2 billion in 2022, then fell by 2.28% to $106.7 billion in 2023, then rose by 9.78% to $117.1 billion in 2024, then rose by 16.87% to $136.9 billion in 2025.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $136.9 billion, $129.5 billion, and $117.5 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.